BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2300478
,
BRCA1
,
glucose metabolic process
,
Hepatitis
,
Prostate
,
Anticancer prodrugs
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
XM_006241191
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Pericardium
Endometrium
Peritoneum
Cervix
Myometrium
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Stachybotryotoxicosis
Toxic effect of mycotoxin
Cerebral palsy
Dehydration
Williams syndrome
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
cidofovir
8-Bromo Cyclic Adenosine Monophosphate
PFI-3
Methyltransferase Inhibitors
senkirkine
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
CTCFL
NFKB2
GHRH
GHR
LBR
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
GH and IGF1 in cancer therapy resistance.
Pleiotropic Effects of IGF1 on the Oocyte.
Effects of propofol on IGF-1 activity and cell behaviour in the GES 1 mucosal cell model.
The common variant of rs6214 in insulin like growth factor 1 (IGF1) gene: a potential protective fac…
CTCF variant begets to short stature by down-regulation of IGF1.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for XM_006241191
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ